1. Korzh E.V., Tlustova T.V. Impact of antiretroviral therapy on tuberculosis encephalomeningitis in HIV infected patients. Probl. Zdorovya i Ekologii, 2014, vol. 39, no. 1, pp. 63-67. (In Russ.)
2. Lyakh Yu.E., Guryanov V.G., Khomenko V.N., Panchenko O.А. Osnovy kompyuternoy biostatistiki. Аnaliz informatsii v biologii, meditsine i farmatsii statisticheskim paketom MedStat. [Basics of computer biostatistics. Data analysis in biology, medicine and pharmacy by MedStat software]. Donetsk, 2006, 214 p.
3. Lawn Stephen D., Robin Wood. Poor prognosis of HIV-associated tuberculous meningitis regardless of the timing of antiretroviral therapy. Clin. Infect. Dis., 2011, vol. 52, is. 11, pp. 1384-1387.
4. Marais S., Thwaites G., Schoeman J.F., Török M.E., Misra U.K., Prasad K., Donald P.R., Wilkinson R.J., Marais B.J. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect. Dis., 2010, vol. 10, is. 11, pp. 803-812. doi: 10.1016/S1473-3099(10)70138-9.
5. Naomi F. Walker, Cari Stek, Sean Wasserman, Robert J. Wilkinson, Graeme Meintjes. The tuberculosis-associated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research. Curr. Opin. HIV AIDS, 2018, vol. 13, is. 6, pp. 512-521. doi: 10.1097/COH.0000000000000502.